1 | Hurwitz et al, 200479 | Bevacizumab plus irinotecan, fluorouracil, and leucovorin formetastatic colorectal cancer (New England Journal of Medicine). | Research | 5,500 | Duke University Medical Center, Durham, North Carolina, (United States). |
2 | Choo et al, 198980 | Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome (Science). | Research | 5,227 | Chiron Corporation, Emeryville, California, (United States) |
3 | Pugh et al, 197381 | Transection of the oesophagus for bleeding oesophageal varices. (British Journal of Surgery) | Research | 4,630 | King's College Hospital and Medical School, London, (United Kingdom). |
4 | Manns et al, 200182 | Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial (Lancet). | Research | 4,438 | Division of Gastroenterology and Hepatology, Medical School of Hannover, Hannover, (Germany). |
5 | Fried et al, 200283 | Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. (New England Journal of Medicine). | Research | 4,363 | University of North Carolina, Chapel Hill (United States). |
6 | Llovet et al, 200884 | Sorafenib in advanced hepatocellular carcinoma. (New England Journal of Medicine). | Research | 3,355 | Barcelona Clínic Liver Cancer Group, Liver Unit, Barcelona, (Spain). |
7 | Kinzler and Vogelstein, 199685 | Lessons from hereditary colorectal cancer (Cell). | Review | 3,325 | The Johns Hopkins Oncology Center, Baltimore, Maryland (United States). |
8 | Perna et al, 200186 | Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. (Nature). | Research | 3,306 | Genome Center of Wisconsin, University of Wisconsin, Madison, (United States) |
9 | Hugot et al, 200187 | Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. (Nature). | Research | 3,185 | Fondation Jean Dausset CEPH, Paris, (France). |
10 | Tomb et al, 199788 | The complete genome sequence of the gastric pathogen Helicobacter pylori. (Nature). | Research | 3,173 | Institute for Genomic Research, Rockville, Maryland 20850, (United Stats). |
11 | Mazzaferro et al, 199689 | Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. (New England Journal of Medicine). | Research | 3,154 | Department of Surgery, National Cancer Institute, Milan, (Italy). |
12 | Bruix and Sherman, 200525 | Management of hepatocellular carcinoma (Hepatology) | Practice guideline | 2,959 | University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, (Spain). |
13 | Kuo et al, 198990 | An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. (Science). | Research | 2,951 | Chiron Corporation, Emeryville, California, (United States). |
14 | Ogura et al, 200191 | A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. (Nature). | Research | 2,917 | The University of Michigan Medical School, Ann Arbor, Michigan, (United States). |
15 | Parsonnet et al, 199192 | Helicobacter pylori infection and the risk of gastric carcinoma. (New England Journal of Medicine). | Research | 2,913 | Department of Medicine, Stanford University School of Medicine, California, (United States). |
16 | Knodell et al, 198126 | Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. (Hepatology). | Research | 2,890 | Gastroenterology Section, Veterans Administration Medical Center, Minneapolis, Minnesota, (United States). |
17 | Dixon et al, 199693 | Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. (The American Journal of Surgical Pathology). | Article | 2,874 | University of Leeds, (United Kingdom). |
18 | Burris et al, 199794 | Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. (Journal of Clinical Oncology). | Research | 2,830 | Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, Texas, (United States). |
19 | Cunningham et al, 200495 | Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. (New England Journal of Medicine). | Research | 2,772 | Royal Marsden Hospital, London, (United Kingdom). |
20 | Hayashi et al, 200196 | Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. (DNA Research). | Research | 2,755 | Department of Microbiology, Miyazaki Medical College, Kiyotake, (Japan). |
21 | Feder et al, 199697 | A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. (Nature Genetics). | Research | 2,744 | Mercator Genetics, Inc., Menlo Park, California, (United States) |
22 | McHutchison et at, 199898 | Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. (New England Journal of Medicine). | Research | 2,639 | Division of Gastroenterology- Hepatology, Scripps Clinic and Research Foundation, La Jolla, California, (United States). |
23 | Groux et al, 199799 | A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. (Nature) | Research | 2,627 | DNAX Research Institute of Molecular and Cellular Biology, Inc., Human Immunology Department, Palo Alto, California, (United States). |
24 | Morin et al, 1997100 | Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. (Science) | Research | 2,613 | Howard Hughes Medical Institute and Johns Hopkins Oncology Center, Baltimore, Maryland, (United States). |
25 | Ishak et al, 199527 | Histological grading and staging of chronic hepatitis. (Journal of Hepatology). | Article | 2,603 | Armed Forces Institute of Pathology, Washington, (United States). |
26 | Nataro and Kaper, 1998101 | Diarrheagenic Escherichia coli. (Clinical Microbiology Reviews). | Review | 2,568 | Department of Medicine, University of Maryland School of Medicine, Baltimore, (United States). |
27 | Boland et al, 1998102 | A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. (Cancer Research) | Review | 2,559 | University of California, San Diego, (United States). |
28 | Bruix et al, 200128 | Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver ( Journal of Hepatology). | Article | 2,467 | Liver Unit, Digestive Disease Institute, Hospital Clinic, IDIBAPS, Barcelona, Catalonia, (Spain). |
29 | Llovet et al, 2003103 | Hepatocellular carcinoma. (Lancet). | Review | 2,401 | Barcelona-Clínic Liver Cancer Group, Liver Unit, Digestive Disease Institute, IDIBAPS, University of Barcelona, Barcelona, (Spain). |
30 | Demetri et al, 2002104 | Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. (New England Journal of Medicine). | Research | 2,383 | Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA, (United States). |
31 | Winawer et al, 1993105 | Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. (New England Journal of Medicine). | Research | 2,355 | Gastroenterology and Nutrition Service, Memorial Sloan-Kettering Cancer Center, New York, (United States). |
32 | Aaltonen et al, 1993.106 | Clues to the pathogenesis of familial colorectal cancer. (Science). | Research | 2,337 | Department of Medical Genetics, University of Helsinki, (Finland). |
33 | Bombardier et al, 2000107 | Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. (New England Journal of Medicine). | Research | 2,315 | Institute for Work and Health, Mount Sinai Hospital, and the University Health Network, Toronto, ON, (Canada). |
34 | Best et al, 197629 | Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study (Gastroenterology) | Research | 2,263 | University of Colorado Medical Center, Denver, Colorado, (United States) |
35 | Thiebaut et al, 1987108 | Cellular localization of the multidrug-resistance gene product P- glycoprotein in normal human tissues (Proceedings of the National Academy of Sciences of the United States of America). | Research | 2,245 | Laboratory of Molecular Biology, National Cancer Institute, Bethesda, MD, (United States). |
36 | Kleiner et al, 200530 | Design and validation of a histological scoring system for nonalcoholic fatty liver disease. (Hepatology) | Research | 2,222 | Laboratory of Pathology, National Cancer Institute, Bethesda, MD, (United States) |
37 | Fishel et al, 1993109 | The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. (Cell). | Research | 2,207 | Department of Microbiology and Molecular Genetics Markey Center for Molecular Genetics University of Vermont Medical School Burlington, (United States) |
38 | Angulo, 2002110 | Nonalcoholic fatty liver disease. (New England Journal of Medicine). | Review | 2,202 | Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, Minnesota, (United States). |
39 | Targan et al, 1997111 | A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. (New England Journal of Medicine). | Research | 2,173 | Cedars-Sinai Medical Center, Los Angeles, California (United States). |
40 | Stocker et al, 1987112 | Bilirubin is an antioxidant of possible physiological importance (Science). | Research | 2147 | University of California, Berkeley, Department of Biochemistry, Berkeley, California (United States). |
41 | Podolsky, 2002113 | Inflammatory bowel disease. (New England Journal of Medicine). | Review | 2,118 | Gastrointestinal unit and the Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital and Harvard Medical School, Boston, (United States). |
42 | de Gramont et al, 2000114 | Leucovorin and fluorouracil with or without oxaliplatin as first- line treatment in advanced colorectal cancer. (Journal of Clinical Oncology). | Research | 2,094 | Service de Médecine Interne-Oncologie, Hôpital Saint-Antoine, Paris, (France). |
43 | Hadziyannis et al, 2004115 | Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. (Annals of Internal Medicine) | Research | 2,063 | Department of Medicine and Hepatology, Henry Dunant Hospital, Athens, (Greece). |
44 | Mandel et al, 1993116 | Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. (New England Journal of Medicine). | Research | 2,047 | Division of Environmental and Occupational Health, University of Minnesota, Minneapolis, (United States). |
45 | Saltz et al, 2000117 | Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. (New England Journal of Medicine). | Research | 2,040 | Memorial Sloan-Kettering Cancer Center, New York, (united States). |
46 | Uemura et al, 2001118 | Helicobacter pylori infection and the development of gastric cancer. (New England Journal of Medicine). | Research | 2,039 | Department of Gastroenterology, Kure Kyosai Hospital, Kure City, (Japan) |
47 | Desmet et al, 199431 | Classification of chronic hepatitis: diagnosis, grading and staging. (Hepatology). | Review | 2038 | Department of Pathology, Catholic University of Leuven, (Belgium). |
48 | Beasley et al, 1981119 | Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. (Lancet). | Research | 2,029 | University Washington Medical Research Unit, Taipei, Taiwan. |
49 | El-Serag and Rudolph, 200732 | Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. (Gastroenterology). | Review | 2,028 | Michael E. DeBakey Veterans Administration Medical Center and Baylor College of Medicine, Houston, Texas, (United States) |
50 | Eberhart et al, 199433 | Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. (Gastroenterology) | Research | 1,929 | Vanderbilt University Medical Center, Nashville, Tennessee (United States). |